Key Market Indicators
The Slovene antidepressant medicine market is projected to contract, reaching approximately $10 million by 2028, down from $12 million in 2023. This represents an annual decline of about 3%. Since 2011, the Slovene market has consistently shrunk at an average annual rate of 1.3%. In 2023, Slovenia ranked 14th globally in terms of antidepressant sales. Denmark led the rankings with sales hitting $12 million. Spain, Italy, and Australia followed Denmark, occupying the second, third, and fourth spots, respectively.
